![]() | |
Supplier Name | BOC Sciences |
Contact | Linna Green |
Tel | +16314854226 |
Mobile | +16314854226 |
info@bocsci.com | |
Website | https://www.bocsci.com/ |
https://www.linkedin.com/company/boc-sciences |
Product Name | Plitidepsin |
Synonyms | Aplidin Plitidepsin cyclic peptide deriv. Didemnin A, N-(1-(1,2-dioxopropyl)-L-prolyl)- 2-9-Didemnin B, 2-(1-(1,2-dioxopropyl)-L-proline)- 3,6-Anhydro-(N-{(2S,4S)-4-[(3S,4R,5S)-3-hydroxy-4-{[N-(2-oxo-propanoyl)-L-prolyl-N-Methyl-D-leucyl-L-threonyl]aMino}-5-Methyl-heptanoyloxy]-2,5-diMethyl-3-oxohexanoyl}-L-leucyl-L-prolyl-N |
CAS | 137219-37-5 |
EINECS | |
Chemical Formula | C57H87N7O15 |
Molecular Weight | 1110.34 |
inchi | |
Package | 1 mg |
Price | $1,099 |
Descriptions | Plitidepsin Plitidepsin is a cyclic depsipeptide isolated from the marine tunicate Aplidium albicans. Plitidepsin shows potent anticancer activity against a large variety of cultured human cancer cells, inducing apoptosis by triggering mitochondrial cytochrome c release, initiating the Fas/DC95, JNK pathway and activating caspase 3 activation. This agent also inhibits elongation factor 1-a, thereby interfering with protein synthesis, and induces G1 arrest and G2 blockade, thereby inhibiting tumor cell growth. |
Supplier Website | https://www.bocsci.com/product/plitidepsin-cas-137219-37-5-305469.html |
Last Update | 2025-04-30 11:27:47 |